cincinnatichildrens.org shows its articles on its own site.
Read the article on cincinnatichildrens.org ↗Article · Nov 2026 · 1 min read
In brief
In brief
The Cancer and Blood Diseases Institute conducts translational research combining laboratory discoveries with clinical trials to develop novel treatments for pediatric cancer and hematologic disorders. Scientists and clinicians collaborate to advance therapeutic options for children with malignancies and blood diseases.
Written by the GCMD Library team from the article.
Explore research at the Cancer and Blood Diseases Institute, where scientists and clinicians advance discoveries, clinical trials and treatments for children.
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Article
Publications
Joseph G. Pressey · Published Nov 2026
Article
Research | Division of Oncology
Joseph G. Pressey · Published Nov 2026
Article
Embryonal rhabdomyosarcoma with a novel t(2;6)(p23;p21.1).
Joseph G. Pressey · Published Nov 2026
Article
Newsroom
Alessandro de Alarcon · Published Oct 2026
Article
Support Services | Cincinnati Children's Research Foundation
Alessandro de Alarcon · Published Oct 2026
Article
Pdf Non Discrimination Statement.Pdf
Alessandro de Alarcon · Published Oct 2026
Article
In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study.
Joseph G. Pressey · Published Nov 2026
Article
Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas.
Joseph G. Pressey · Published Nov 2026
Article
Current concepts on the surgical and medical management of osteosarcoma.
Joseph G. Pressey · Published Nov 2026
Article
Zoledronic acid in metastatic osteosarcoma: encouraging progression free survival in four consecutive patients.
Joseph G. Pressey · Published Nov 2026
Article
Using cancer phenotype sex-specificity to enable unbiased penetrance estimation of SMARCA4 pathogenic variants for small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).
Joseph G. Pressey · Published Nov 2026
Article
CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV.
Joseph G. Pressey · Published Nov 2026